Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
AbstractThis study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from different parts of the world (U.S.A., United Kingdom, Europe, India, etc.) were reviewed in a structured manner to understand different assumptions, outcomes obtained and issues, identified/addressed/raised by the different QPhRA studies. Till date, most of the published studies have concluded that there is no appreciable risk to human health during environmental exposures of pharmaceuticals; however, attention is still required to following identified issues: (1) Use of measured versus predicted pharmaceutical concentration, (2) Identification of pharmaceuticals-of-concern and compounds needing special considerations, (3) Use of source water versus finished drinking water-related exposure scenarios, (4) Selection of representative exposure routes, (5) Valuation of uncertainty factors, and (6) Risk assessment for mixture of chemicals. To close the existing data and methodology gaps, this study proposed possible ways to address and/or incorporation these considerations within the QPhRA framework; however, more research work is still required to address issues, such as incorporation of short-term to long-term extrapolation and mixture effects in the QPhRA framework. Specifically, this study proposed a development of a new “mixture effects-related uncertainty factor” for mixture of chemicals (i.e., mixUFcomposite), similar to an uncertainty factor of a single chemical, within the QPhRA framework. In addition to all five traditionally used uncertainty factors, this uncertainty factor is also proposed to include concentration effects due to presence of different range of concentration levels of pharmaceuticals in a mixture. However, further work is required to determine values of all six uncertainty factors and incorporate them to use during estimation of point-of-departure values within the QPhRA framework. View Full-Text
Share & Cite This Article
Kumar, A.; Chang, B.; Xagoraraki, I. Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead. Int. J. Environ. Res. Public Health 2010, 7, 3929-3953.
Kumar A, Chang B, Xagoraraki I. Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead. International Journal of Environmental Research and Public Health. 2010; 7(11):3929-3953.Chicago/Turabian Style
Kumar, Arun; Chang, Biao; Xagoraraki, Irene. 2010. "Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead." Int. J. Environ. Res. Public Health 7, no. 11: 3929-3953.